PG
CMD

PEAK6 Group’s Cantel Medical Corporation CMD Stock Holding History

PEAK6 Group’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$698K Sell
7,100
-5,400
-43% -$604K ﹤0.01% 2285
2018
Q1 		$1.39M Buy
12,500
+4,000
+47% +$448K 0.01% 1674
2017
Q4 		$874K Sell
8,500
-100
-1% -$9.96K ﹤0.01% 2030
2017
Q3 		$810K Buy
8,600
+4,700
+121% +$371K ﹤0.01% 2148
2017
Q2 		$304K Sell
3,900
-10,300
-73% -$774K ﹤0.01% 2977
2017
Q1 		$1.14M Buy
14,200
+5,700
+67% +$453K 0.01% 1568
2016
Q4 		$669K Buy
8,500
+8,300
+4,150% +$645K ﹤0.01% 2236
2016
Q3 		$16K Buy
+200
New +$14.5K ﹤0.01% 4129
2016
Q1 		– Sell
-2,500
Closed -$155K – 5258
2015
Q4 		$155K Buy
+2,500
New +$153K ﹤0.01% 3641
2014
Q2 		– Sell
-16,200
Closed -$546K – 5320
2014
Q1 		$546K Buy
16,200
+700
+5% +$23.1K ﹤0.01% 2471
2013
Q4 		$526K Buy
+15,500
New +$537K ﹤0.01% 2623

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

PEAK6 Group's CMD Position: Q2 2017 in Review

PEAK6 Group sold out of Cantel Medical Corporation (CMD) in Q2 2017, closing a stake of 7,706 shares — an estimated $579K sold.

PEAK6 Group first reported a position in CMD in Q4 2013 and held it in 4 quarters. The position peaked at $617K in Q1 2017. 214 funds tracked by Wall St. Rank hold CMD as of Q2 2017.

  • PEAK6 Group reported no remaining Cantel Medical Corporation position as of Q2 2017 after selling out during the quarter.
  • PEAK6 Group sold 7,706 Cantel Medical Corporation shares in Q2 2017, an estimated $579K.
  • PEAK6 Group first reported a position in Cantel Medical Corporation in Q4 2013 and held it in 4 quarters.
  • PEAK6 Group's Cantel Medical Corporation position peaked at $617K in Q1 2017.
  • 214 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2017.

Based on PEAK6 Group's 13F filing for Q2 2017, filed 14 Aug 2017.